Biora Therapeutics, Inc. Operating Lease, Expense
Biora Therapeutics, Inc. reported Operating Lease, Expense of $5.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-11-14
- Biora Therapeutics, Inc. operating lease, expense for the quarter ending 2021-12-31 was $1.10M, a 0.00% change year-over-year.
- Biora Therapeutics, Inc. operating lease, expense for the quarter ending 2021-09-30 was $800.00K, a 42.86% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, expense for the quarter ending 2021-06-30 was $1.70M, a 183.33% increase year-over-year.
- Biora Therapeutics, Inc. operating lease, expense for the quarter ending 2021-03-31 was $400.00K, a 80.95% decline year-over-year.
- Biora Therapeutics, Inc. operating lease, expense for fiscal 2021 was $5.10M, a 13.56% decline from fiscal 2020.
- Biora Therapeutics, Inc. operating lease, expense for fiscal 2020 was $5.90M, a 33.71% decline from fiscal 2019.
- Biora Therapeutics, Inc. operating lease, expense for fiscal 2019 was $8.90M.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 3 month as first filed | Operating Lease, Expense 6 month | Operating Lease, Expense 6 month as first filed | Operating Lease, Expense 9 month | Operating Lease, Expense 9 month as first filed | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $1.90M derived: sum of 2 quarters · filed 2022-11-14 | $3.60M derived: sum of 3 quarters · filed 2022-11-14 | $5.10M 10-K · filed 2022-03-28 | ||||
| 2021-09-30 | $800.00K 10-Q · filed 2022-11-14 | $2.50M derived: sum of 2 quarters · filed 2022-11-14 | $4.00M 10-Q · filed 2022-11-14 | $4.00M derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $1.70M 10-Q · filed 2022-08-15 | $3.10M 10-Q · filed 2022-08-15 | $3.20M derived: sum of 3 quarters · filed 2022-08-15 | $4.60M derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $400.00K 10-Q · filed 2022-05-10 | $1.90M 10-Q · filed 2021-05-13 | $1.50M derived: sum of 2 quarters · filed 2022-05-10 | $2.90M derived: sum of 3 quarters · filed 2022-05-10 | $3.50M derived: sum of 4 quarters · filed 2022-05-10 | |||
| 2020-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $2.50M derived: sum of 2 quarters · filed 2022-03-28 | $3.10M derived: sum of 3 quarters · filed 2022-03-28 | $5.90M 10-K · filed 2022-03-28 | $7.60M 10-K · filed 2021-03-18 | |||
| 2020-09-30 | $1.40M 10-Q · filed 2021-11-10 | $1.80M 10-Q · filed 2020-11-09 | $2.00M derived: sum of 2 quarters · filed 2021-11-10 | $4.80M 10-Q · filed 2021-11-10 | $6.00M 10-Q · filed 2020-11-09 | $6.40M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $600.00K 10-Q · filed 2021-08-12 | $2.00M 10-Q · filed 2020-08-14 | $3.40M 10-Q · filed 2021-08-12 | $4.20M 10-Q · filed 2020-08-14 | $5.00M derived: sum of 3 quarters · filed 2021-08-12 | $7.30M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $2.10M 10-Q · filed 2021-05-13 | $4.40M derived: sum of 2 quarters · filed 2021-05-13 | $6.70M derived: sum of 3 quarters · filed 2021-05-13 | $8.90M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $4.60M derived: sum of 2 quarters · filed 2021-03-18 | $6.80M derived: sum of 3 quarters · filed 2021-03-18 | $8.90M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $2.30M 10-Q · filed 2020-11-09 | $4.50M derived: sum of 2 quarters · filed 2020-11-09 | $6.60M 10-Q · filed 2020-11-09 | |||||
| 2019-06-30 | $2.20M 10-Q · filed 2020-08-14 | $4.30M 10-Q · filed 2020-08-14 |